Hadensa Ointment

Introduction

Hadensa is a topical medication that contains the active ingredients Lanolin, Lidocaine, Menthol, and Thymol. It is available both as a prescription and over-the-counter (OTC) product. This ointment is commonly used for its soothing and numbing properties, providing relief for various skin conditions.

Uses

Hadensa is indicated for the temporary relief of pain and itching associated with minor skin irritations, such as insect bites, poison ivy, sunburn, and minor cuts or scrapes. It can also be used to relieve discomfort caused by hemorrhoids.

Dosage and Administration

For adults and children 2 years of age and older, apply a thin layer of Hadensa to the affected area up to 3 to 4 times daily, or as directed by your healthcare provider. Gently massage the ointment into the skin until it is fully absorbed. Avoid applying the ointment to broken or irritated skin.

Mechanism of Action

Hadensa works by combining the properties of its active ingredients to provide relief. Lanolin acts as a moisturizer and skin protectant, while Lidocaine is a local anesthetic that helps numb the area. Menthol and Thymol have a cooling effect and can help alleviate itching.

Side Effects

Common side effects may include skin irritation, redness, or a mild burning or stinging sensation at the application site. These side effects are usually temporary and should subside on their own. However, if you experience any severe or persistent side effects, such as allergic reactions or worsening skin symptoms, seek medical attention immediately.

Drug Interactions

Hadensa may interact with certain medications, including other topical products or medications applied to the same area. Inform your healthcare provider about all the medications, supplements, and herbal products you are currently using, to avoid any potential interactions.

Precautions

Before using Hadensa, inform your healthcare provider if you have any known allergies to Lanolin, Lidocaine, Menthol, Thymol, or any other ingredients in the ointment. Additionally, inform your healthcare provider about any other medical conditions you have, especially if you have a history of skin sensitivities or if you are pregnant or breastfeeding.

Avoid applying Hadensa to open wounds or broken skin, as it may cause increased absorption of the active ingredients. Do not bandage or cover the treated area tightly, as this may increase the risk of side effects.

Storage

Store Hadensa at room temperature, away from excessive heat or direct sunlight. Keep the ointment out of reach of children and pets. Do not use the ointment if it has expired or if the packaging is damaged.

Patient Tips

• Wash your hands thoroughly before and after applying Hadensa to prevent the spread of germs.
• Avoid contact with the eyes or mucous membranes. In case of accidental contact, rinse thoroughly with water.
• If your symptoms do not improve or worsen after a few days of using the ointment, consult your healthcare provider.
• If you are using other topical medications or products on the same area, wait for at least 10-15 minutes before applying Hadensa to prevent interactions.
• If you have any concerns or questions about using Hadensa, consult your healthcare provider or pharmacist for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Chair-based pilates video workout (NHS UK) [Accessed 25 Jun. 2024] (online) Available at:
• E45 Cream (Health Professionals SmPC) Available at:
• Exodus Paste (23.6 g) for Animal Use (Canada) (Drugs.com) [Accessed 10 Jun. 2024] (online) Available at:
• artificial tears with lanolin ointment (OTC) [Accessed 1 Jun. 2024] (online) Available at:
• Lanolin poisoning (MedlinePlus) [Accessed 11 Jun. 2024] (online) Available at:
• DeVito EE, Krishnan-Sarin S. E-cigarettes: Impact of E-Liquid Components and Device Characteristics on Nicotine Exposure. Curr Neuropharmacol. 2018;16(4):438-459. doi: 10.2174/1570159X15666171016164430. [Accessed 23 Jun. 2024] Available at: